Overexpression of CDCP1 is Associated with Poor Prognosis and Enhanced Immune Checkpoints Expressions in Breast Cancer

Figure 2

Expression of CDCP1 in BrCa tissues with various stages and subtypes. (a, b) Comparison of CDCP1 mRNA expression in BrCa tissues with various stages and subtypes in the TCGA dataset based on data mining via UALCAN. (c, d) Comparison of CDCP1 protein expression in BrCa tissues with various stages and subtypes in the CPTAC dataset based on data mining via UALCAN. (e, f) Comparison of CDCP1 protein expression in BrCa tissues with various stages and subtypes in the in-house cohort.

(a)

(b)

(c)

(d)

(e)

(f)